Fund Management At Engine No. 1 LLC Edwards Lifesciences Corp Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $55,493 - $74,797	801 Added 10.15%	8,693 $602,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $32,238 - $37,354	396 Added 5.28%	7,892 $744,000
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $51,239 - $58,311	690 Added 10.14%	7,496 $620,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $57,850 - $74,061	847 Added 14.21%	6,806 $507,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $490,842 - $639,341	5,959 New	5,959 $492,000
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $457,239 - $678,035	-5,286 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $538,960 - $678,405	5,286 New	5,286 $622,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.